Cargando…
ODP482 Graves Orbitopathy Secondary to Alemtuzumab Infusion for Multiple Sclerosis
: Presentation: This is a 51-year-old male with a history of Graves disease who presented to the ED with worsening proptosis and 10/10 eye pain. He reported being unable to shut his eyes, photophobia, decreased vision, and extreme eye sensitivity to touch. He was initially diagnosed with Graves dis...
Autores principales: | Alam, Mustafa, Abdelrahim, Baha, Hosam Horani, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625766/ http://dx.doi.org/10.1210/jendso/bvac150.1582 |
Ejemplares similares
-
ODP487 Iatrogenic Thyroid Storm Treated with Plasmapheresis
por: Alam, Mustafa, et al.
Publicado: (2022) -
ODP523 Thyroid Storm in a Patient With Alemtuzumab Induced Graves’ Disease
por: AlShehri, Sara, et al.
Publicado: (2022) -
ODP502 Nodular Pretibial Myxedema without Graves’ Orbitopathy: A Case Report
por: Veeramachaneni, Ravali, et al.
Publicado: (2022) -
ODP326 Isolated Abducens Palsy as a Presenting Feature of Pituitary Apoplexy
por: Alam, Mustafa, et al.
Publicado: (2022) -
An Unusual Etiology of Graves’ Disease: Alemtuzumab
por: Santiago Carrion, Ada Marie, et al.
Publicado: (2021)